Dual targeting of GPX4 and TXNRD1 triggers eradication of AML cells through induction of apoptosis and ferroptosis

Abstract Myelodysplastic syndromes (MDS) are hematological disorders associated with bone marrow failure and abnormal hematopoietic cell growth, often progressing to acute myeloid leukemia (AML). Current treatments for AML and high-risk MDS are limited in efficacy, highlighting the need for new ther...

全面介紹

書目詳細資料

Principais autores:	Cécile Favreau, Maxence Bourgoin, Coline Savy, Thomas Botton, Sarah Bailly, Florence Granger, Catherine Birck, Marwa Zerhouni, Emeline Kerreneur, Adele Rivault, Alban Vigroux, Jade Dussart-Gautheret, Marie-Laure Arcangeli, Arnaud Poterszman, Thomas Cluzeau, Stephane Rocchi, Arnaud Jacquel, Rachid Benhida, Patrick Auberger, Anthony R. Martin, Guillaume Robert
格式:	Artigo
語言:	Inglês
出版:	BMC 2026-03-01
叢編:	Experimental Hematology & Oncology
主題:	Acute myeloid leukemia Covalent inhibitor Targeted therapies GPX4 TXNRD1 Ferroptosis
在線閱讀:	https://doi.org/10.1186/s40164-026-00766-4
標簽:	添加標簽 沒有標簽, 成為第一個標記此記錄!